Autologous conditioned serum in the therapy of obesity-related knee osteoarthritis
DOI:
https://doi.org/10.2478/AMB-2026-0056Keywords:
obesity-related knee osteoarthritis, autologous conditioned serum, intra-articular injection, pain, knee function, treatmentAbstract
Abstract. Introduction: Knee osteoarthritis (KOA) is a common joint disorder affecting the elderly population. Conservative treatment includes lifestyle modifications, weight loss, physiotherapy, nonsteroidal anti-inflammatory drugs, chondroprotective agents, intra-articular application of steroids, hyaluronic acid, and autologous blood component injections. Obesity-related KOA has recently been extensively studied as a separate disease, and there are currently no explicit guidelines regarding its treatment. Currently, there is only a few literature data on the intra-articular administration of autologous conditioned serum (ACS) in subjects with KOA, which suggests an improvement in pain management and functional impairment. However, no separate studies have been performed for obesity-related KOA. Therefore, the aim of our study was to evaluate the efficacy and safety of ACS in the treatment of obesity-related KOA. Materials and methods: A total of 20 patients with Kellgren-Lawrence (KL) grade 2-3 obesity-related KOA were included in the present study, all of whom received intra-articular ACS. Demographic data and routine laboratory examinations were performed and musculoskeletal ultrasound was used to assess for synovitis prior to intervention. Pain and functional impairment were assessed through visual analogue scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) prior to intervention, 1 week and 6 months post-treatment. Results: We reported a statistically significant decrease in pain and functional improvement 1 week post-treatment, which persisted up to 6 months post-treatment. Better improvement was noted in KL grade 2 and in subjects with synovitis. There were no major adverse events reported. Conclusions: The intra-articular administration of ACS provides rapid improvement of pain and functional impairment in obesity-related KOA, which persists up to 6 months post-treatment.
References
Palazzo C, Nguyen C, Lefevre-Colau MM, et al. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med, 2016;59(3):134-138.
Shumnalieva R, Kotov G, Monov S. Obesity-Related Knee Osteoarthritis-Current Concepts. Life (Basel), 2023;13(8):1650.
Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet, 2011;377(9783):2115-2126.
Leone R, de Rosa A, Iudicone P, et al. Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet-rich plasma treatments in knee osteoarthritis. Transfus Med, 2021;31(5):357-364.
Ren JL, Yang J, Hu W. The global burden of osteoarthritis knee: a secondary data analysis of a population-based study. Clin Rheumatol, 2025;44(4):1769-1810.
Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol, 2014;28(1):5-15.
Safiri S, Kolahi AA, Smith E, et al. Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis, 2020;79(6):819-828.
Cheng P-G, Yang KD, Huang L-G, et al. Comparisons of cytokines, growth factors, and clinical efficacy between platelet-rich plasma and autologous conditioned serum for knee osteoarthritis management. Biomolecules, 2023;13(3):555.
D’Gasper D, Bains BS, Sadeghi H, et al. Comparing exercise prescription methods in knee osteoarthritis patients in Malaysia. Acta Medica Bulg, 2018;45(1):26-31.
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage, 2019;27:1578-1589.
Vassileva D, Nedelcheva I, Mindova S, et al. The influence of gait patterns with aids on the patient’s recovery in the early period following total knee replacement. Acta Medica Bulg, 2019;46(2):36-40.
Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline forthe management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken), 2020;72(2):149-162.
Chen L, Zheng JJY, Li G, et al. Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. J Orthop Translat, 2020;24:66-75.
Raud B, Gay C, Guiguet-Auclair C, et al. The level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Sci Rep, 2020;10(1):3601.
Pan F, Tian J, Cicuttini F, et al. Metabolic syndrome and trajectory of knee pain in older adults. Osteoarthritis Cartilage, 2020;28(1):45-52.
Xiong J, Long J, Chen X, et al. Dyslipidemia might be associated with an increased risk of osteoarthritis. Biomed Res Int, 2020;2020:3105248.
Conrozier T. How to treat osteoarthritis in obese patients? Curr Rheumatol Rev, 2020;16(2):99-104.
Shumnalieva R, Kotov G, Ermencheva P, et al. Pathogenic mechanisms and therapeutic approaches in obesity-related knee osteoarthritis. Biomedicines, 2023;12(1):9.
Khurana A, Goyal A, Kirubakaran P, et al. Efficacy of autologous conditioned serum (ACS), platelet-rich plasma (PRP), hyaluronic Acid (HA), and steroid for early osteoarthritis knee: a comparative analysis. Indian J Orthop, 2020;55(Suppl 1):217-227.
Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med, 2014;42(1):35-41.
Navani A, Li G, Chrystal J. Platelet-rich plasma in musculoskeletal pathology: a necessary rescue or a lost cause? Pain Physician, 2017;20(3):E345-E356.
Pachito DV, Latorraca COC, Riera R. Efficacy of platelet-rich plasma for non-transfusion use: Overview of systematic reviews. Int J Clin Pract, 2019;73(11):e13402.
Zhao J, Huang H, Liang G, et al. Effects and safety of the combination of platelet-rich plasma (PRP) and hyaluronic acid (HA) in the treatment of knee osteoarthritis: a systematic review and meta-analysis. BMC Musculoskelet Disord, 2020;21(1):224.
Baltzer AW, Moser C, Jansen SA, et al. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage, 2009;17(2):152-60.
Vitali M, Ometti M, Drossinos A, et al. Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritis. J Drug Assess, 2020; 9(1):43-51.
Sobieh BH, El-Mesallamy HO, Kassem DH. Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets. Heliyon, 2023;9(5):e15700.
Darabos N, Haspl M, Moser C, et al. Intraarticular application of autologous conditioned serum (ACS) reduces bone tunnel widening after ACL reconstructive surgery in a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc, 2011;19(Suppl 1):S36-46.
Du X, Liu ZY, Tao XX, et al. Research progress on the pathogenesis of knee osteoarthritis. Orthop Surg, 2023;15(9):2213-2224.
Frizziero A, Giannotti E, Oliva F, et al. Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders. Br Med Bull, 2013;105:169-84.
Auw Yang KG, Raijmakers NJ, van Arkel ER, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage, 2008;16(4):498-505.
Shirokova L, Noskov S, Gorokhova V, et al. Intra-articular injections of a whole blood clot secretome, autologous conditioned serum, have superior clinical and biochemical efficacy over platelet-rich plasma and induce rejuvenation-associated changes of joint metabolism: a prospective, controlled open-label clinical study in chronic knee osteoarthritis. Rejuvenation Res, 2020;23(5):401-410.
Lv Z, Yang YX, Li J, et al. Molecular classification of knee osteoarthritis. Front Cell Dev Biol, 2021;9:725568.
Li L, Li Z, Li Y, et al. Profiling of inflammatory mediators in the synovial fluid related to pain in knee osteoarthritis. BMC Musculoskelet Disord, 2020;21(1):99.
Nikolova-Shopova S, Aleksiev A, Zaralieva A. Ultrasound, interference current, and exercise for recurrent knee pain due to osteoarthritis. Int J Adv Res, 2021;9(5):647-653.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 G. Kotov, P. Ermencheva, R. Shumnalieva, G. P. Georgiev, A. Zaralieva, S. Monov (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
